Home › Occupations › Regulatory Affairs Specialists › Wilmington, DE
Regulatory Affairs Specialists in Wilmington, DE: H-1B salaries
37 labor condition applications for this occupation with a work site in Wilmington, DE. Median offered base salary $66,622; middle half $66,414–$81,120.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $60,000 |
| Level II (qualified) | $66,622 |
| Level III (experienced) | $89,440 |
| Level IV (fully competent) | $125,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Unicon Pharma Inc | 10 | $66,518 |
| Unicon Sciences Inc | 8 | $66,518 |
| Zenith LifeScience LLC | 6 | $87,360 |
| Incyte Corporation | 3 | $125,000 |
| AstraZeneca Pharmaceuticals LP | 2 | $111,625 |
| Fathom Life Sciences and Technology Solutions, LLC. | 2 | $51,875 |
| Stark Associates LLC | 2 | $76,502 |
| Stark Pharma Solutions Inc. | 2 | $67,621 |
| Katalyst Healthcares & Life Sciences Inc. | 1 | $66,414 |
| Vakula Technologies Inc. | 1 | $80,600 |
Job titles
- Specialist Study Management12
- Study Management Specialist6
- Specialist Clinical Study Management5
- Clinical Regulatory Associate5
- Clinical Study Associate2
- Patient Safety Specialist Operations1
- Principal Drug Safety Associate1
- Senior Manager, GRMSS Portfolio Management1
- Senior Manager, Submission Planning for Global Registration1
- Specialist, Global Patient Safety Compliance, US1
- Specialist Clinical Study Manager1
- Global Strategic Sourcing Analyst1
H-1B sponsors in Wilmington, DE →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).